We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

129 hedge funds and large institutions have $949M invested in Celldex Therapeutics in 2013 Q2 according to their latest regulatory filings, with 129 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less call options, than puts

Call options by funds: $7.11M | Put options by funds: $8.22M

Holders
129
Holders Change
+129
Holders Change %
–
% of All Funds
4.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
129
Increased
–
Reduced
–
Closed
–
Calls
$7.11M
Puts
$8.22M
Net Calls
-$1.11M
Net Calls Change
-$1.11M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$133M +$112M +569,936 New
Jennison Associates
2
Jennison Associates
New York
$72.9M +$61.3M +311,503 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$72.9M +$61.3M +311,215 New
SCA
4
SAC Capital Advisors
Connecticut
$62.4M +$52.5M +266,667 New
BFA
5
BlackRock Fund Advisors
California
$40.6M +$34.2M +173,462 New
State Street
6
State Street
Massachusetts
$39.8M +$33.5M +170,057 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$39.3M +$33.1M +167,860 New
CCI
8
Columbus Circle Investors
$38.1M +$32.1M +162,858 New
BIT
9
BlackRock Institutional Trust
California
$35.4M +$29.8M +151,122 New
Lord, Abbett & Co
10
Lord, Abbett & Co
New Jersey
$28.8M +$24.3M +123,171 New
BA
11
BlackRock Advisors
Delaware
$28.5M +$24M +121,926 New
Wellington Management Group
12
Wellington Management Group
Massachusetts
$25.3M +$21.2M +107,872 New
HM
13
HealthCor Management
New York
$22.6M +$19M +96,667 New
AllianceBernstein
14
AllianceBernstein
Tennessee
$21.9M +$18.4M +93,340 New
TCM
15
TimesSquare Capital Management
New York
$18.5M +$15.6M +79,009 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$18.2M +$15.3M +77,829 New
Northern Trust
17
Northern Trust
Illinois
$18M +$15.1M +76,917 New
TCMG
18
TSP Capital Management Group
New Jersey
$17M – – –
PCA
19
Private Capital Advisors
Connecticut
$12.8M +$10.8M +54,837 New
First Eagle Investment Management
20
First Eagle Investment Management
New York
$10.4M +$8.74M +44,371 New
Morgan Stanley
21
Morgan Stanley
New York
$8.36M +$7.03M +35,705 New
SONJCPFA
22
State of New Jersey Common Pension Fund A
New Jersey
$8.27M +$6.96M +35,333 New
PI
23
Putnam Investments
Massachusetts
$7.96M +$6.69M +33,987 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$6.7M +$5.64M +28,620 New
EA
25
Emerald Advisers
Pennsylvania
$6.54M +$5.5M +27,911 New
1
2 3 4 5

CLDX Hedge Fund Activity: Q2 2013 in Review

129 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q2 2013, worth a combined $949M.

Buyers outnumbered sellers: 129 funds opened new CLDX positions and 0 closed out — a net gain of 129 holders — while 0 added to existing stakes and 0 trimmed.

  • 129 institutional investors held Celldex Therapeutics (CLDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $949M of Celldex Therapeutics stock for Q2 2013.
  • 129 funds opened new Celldex Therapeutics positions in Q2 2013 and 0 closed out, a net change of +129 holders.

Based on aggregated 13F filings for Q2 2013.